University of Cincinnati Research Finds New Option for Transplant Patients
November 09, 2019
November 09, 2019
CINCINNATI, Ohio, Nov. 9 [TNSmedicalresearch-American Association for the Study of Liver Diseases] -- The University of Cincinnati issued the following news:
* * *
- Common drug offers fewer side effects than prednisone, but similar organ rejection rates in liver transplants in preliminary studies
* * *
A drug commonly used to treat both asthma and inflammatory bowel disease, budesonide, may also be useful as an anti-organ rejection medication . . .
* * *
- Common drug offers fewer side effects than prednisone, but similar organ rejection rates in liver transplants in preliminary studies
* * *
A drug commonly used to treat both asthma and inflammatory bowel disease, budesonide, may also be useful as an anti-organ rejection medication . . .